• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究人员应向癌症生物样本库参与者的家庭成员提供研究结果吗?一项关于先证者及其家属偏好的混合方法研究。

Should Researchers Offer Results to Family Members of Cancer Biobank Participants? A Mixed-Methods Study of Proband and Family Preferences.

作者信息

Gordon Deborah R, Radecki Breitkopf Carmen, Robinson Marguerite, Petersen Wesley O, Egginton Jason S, Chaffee Kari G, Petersen Gloria M, Wolf Susan M, Koenig Barbara A

机构信息

a Department of Anthropology, History and Social Medicine , University of California, San Francisco.

b Department of Health Sciences Research , Mayo Clinic.

出版信息

AJOB Empir Bioeth. 2019 Jan-Mar;10(1):1-22. doi: 10.1080/23294515.2018.1546241. Epub 2018 Dec 31.

DOI:10.1080/23294515.2018.1546241
PMID:30596322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6443426/
Abstract

BACKGROUND

Genomic analysis may reveal both primary and secondary findings with direct relevance to the health of probands' biological relatives. Researchers question their obligations to return findings not only to participants but also to family members. Given the social value of privacy protection, should researchers offer a proband's results to family members, including after the proband's death?

METHODS

Preferences were elicited using interviews and a survey. Respondents included probands from two pancreatic cancer research resources, plus biological and nonbiological family members. Hypothetical scenarios based on actual research findings from the two cancer research resources were presented; participants were asked return of results preferences and justifications. Interview transcripts were coded and analyzed; survey data were analyzed descriptively.

RESULTS

Fifty-one individuals (17 probands, 21 biological relatives, 13 spouses/partners) were interviewed. Subsequently, a mailed survey was returned by 464 probands, 1,040 biological family members, and 399 spouses/partners. This analysis highlights the interviews, augmented by survey findings. Probands and family members attribute great predictive power and lifesaving potential to genomic information. A majority hold that a proband's genomic results relevant to family members' health ought to be offered. While informants endorse each individual's choice whether to learn results, most express a strong moral responsibility to know and to share, particularly with the younger generation. Most have few concerns about sharing genetic information within the family; rather, their concerns focus on the health consequences of not sharing.

CONCLUSIONS

Although additional studies in diverse populations are needed, policies governing return of genomic results should consider how families understand genomic data, how they value confidentiality within the family, and whether they endorse an ethics of sharing. A focus on respect for individual privacy-without attention to how the broad social and cultural context shapes preferences within families-cannot be the sole foundation of policy.

摘要

背景

基因组分析可能揭示与先证者生物学亲属健康直接相关的主要和次要发现。研究人员质疑他们不仅有义务将发现结果反馈给参与者,还应反馈给家庭成员。鉴于隐私保护的社会价值,研究人员是否应该将先证者的结果告知家庭成员,包括先证者去世后?

方法

通过访谈和调查来了解偏好。受访者包括来自两个胰腺癌研究资源库的先证者,以及生物学和非生物学家庭成员。呈现基于这两个癌症研究资源库实际研究结果的假设情景;询问参与者对结果反馈的偏好及理由。对访谈记录进行编码和分析;对调查数据进行描述性分析。

结果

对51人(17名先证者、21名生物学亲属、13名配偶/伴侣)进行了访谈。随后,464名先证者、1040名生物学家庭成员和399名配偶/伴侣回复了邮寄的调查问卷。本分析突出了访谈情况,并辅以调查结果。先证者和家庭成员认为基因组信息具有强大的预测能力和挽救生命的潜力。大多数人认为应该提供与家庭成员健康相关的先证者基因组结果。虽然受访者认可每个人是否了解结果的选择,但大多数人表示有强烈的道德责任去了解并分享,尤其是与年轻一代分享。大多数人对在家庭内部分享遗传信息几乎没有顾虑;相反,他们的担忧集中在不分享所带来的健康后果上。

结论

尽管需要在不同人群中开展更多研究,但关于基因组结果反馈的政策应考虑家庭如何理解基因组数据、他们如何重视家庭内部的保密性,以及他们是否认可共享伦理。仅关注尊重个人隐私而不考虑广泛的社会和文化背景如何塑造家庭内部的偏好,不能成为政策的唯一基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4066/6443426/ffbb64c294ac/nihms-1520708-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4066/6443426/ffbb64c294ac/nihms-1520708-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4066/6443426/ffbb64c294ac/nihms-1520708-f0001.jpg

相似文献

1
Should Researchers Offer Results to Family Members of Cancer Biobank Participants? A Mixed-Methods Study of Proband and Family Preferences.研究人员应向癌症生物样本库参与者的家庭成员提供研究结果吗?一项关于先证者及其家属偏好的混合方法研究。
AJOB Empir Bioeth. 2019 Jan-Mar;10(1):1-22. doi: 10.1080/23294515.2018.1546241. Epub 2018 Dec 31.
2
Attitudes Toward Return of Genetic Research Results to Relatives, Including After Death: Comparison of Cancer Probands, Blood Relatives, and Spouse/Partners.对将基因研究结果返还给亲属(包括在亲属去世后)的态度:癌症先证者、血亲及配偶/伴侣的比较
J Empir Res Hum Res Ethics. 2018 Jul;13(3):295-304. doi: 10.1177/1556264618769165. Epub 2018 Apr 27.
3
Ethical concerns on sharing genomic data including patients' family members.关于共享包括患者家庭成员在内的基因组数据的伦理问题。
BMC Med Ethics. 2018 Jun 18;19(1):61. doi: 10.1186/s12910-018-0310-5.
4
Preferences Regarding Return of Genomic Results to Relatives of Research Participants, Including after Participant Death: Empirical Results from a Cancer Biobank.关于向研究参与者亲属反馈基因组结果的偏好,包括参与者死亡后:癌症生物样本库的实证结果
J Law Med Ethics. 2015 Fall;43(3):464-75. doi: 10.1111/jlme.12289.
5
The views of ethics committee members and medical researchers on the return of individual research results and incidental findings, ownership issues and benefit sharing in biobanking research in a South Indian city.印度南部一座城市的伦理委员会成员和医学研究人员对生物样本库研究中个人研究结果和偶发发现的反馈、所有权问题及利益分享的看法。
Dev World Bioeth. 2018 Dec;18(4):321-330. doi: 10.1111/dewb.12143. Epub 2017 May 17.
6
Disclosure to genetic relatives without consent - Australian genetic professionals' awareness of the health privacy law.未经同意向遗传亲属披露信息-澳大利亚遗传专业人员对健康隐私法的认识。
BMC Med Ethics. 2020 Feb 4;21(1):13. doi: 10.1186/s12910-020-0451-1.
7
First Do No Harm: Ethical Concerns of Health Researchers That Discourage the Sharing of Results With Research Participants.首先,勿施伤害:健康研究人员在与研究参与者分享研究结果方面存在的伦理问题。
AJOB Empir Bioeth. 2020 Apr-Jun;11(2):104-113. doi: 10.1080/23294515.2020.1737980. Epub 2020 Mar 12.
8
'Ethical responsibility' or 'a whole can of worms': differences in opinion on incidental finding review and disclosure in neuroimaging research from focus group discussions with participants, parents, IRB members, investigators, physicians and community members.“道德责任”还是“一团麻烦事”:通过与参与者、家长、机构审查委员会成员、研究人员、医生及社区成员进行焦点小组讨论,了解在神经影像研究中对偶然发现的审查与披露方面的意见分歧
J Med Ethics. 2015 Oct;41(10):841-7. doi: 10.1136/medethics-2014-102552. Epub 2015 Jun 10.
9
'Is this knowledge mine and nobody else's? I don't feel that.' Patient views about consent, confidentiality and information-sharing in genetic medicine.“这些知识是我的,别人都没有吗?我不这么觉得。”患者对基因医学中知情同意、保密和信息共享的看法。
J Med Ethics. 2016 Mar;42(3):174-9. doi: 10.1136/medethics-2015-102781. Epub 2016 Jan 7.
10
Genomic information and a person's right not to know: A closer look at variations in hypothetical informational preferences in a German sample.基因组信息与个人的知情权:对德国样本中假设性信息偏好变化的深入观察。
PLoS One. 2018 Jun 20;13(6):e0198249. doi: 10.1371/journal.pone.0198249. eCollection 2018.

引用本文的文献

1
Development of a digital risk-prediction tool based on family health history for the general population: legal and ethical implications.基于家族健康史为普通人群开发数字风险预测工具:法律与伦理问题
J Community Genet. 2025 Feb;16(1):73-81. doi: 10.1007/s12687-024-00761-4. Epub 2024 Dec 14.
2
Returning individual research results to participants: Values, preferences, and expectations.向参与者反馈个体研究结果:价值观、偏好与期望。
J Clin Transl Sci. 2024 Sep 18;8(1):e126. doi: 10.1017/cts.2024.568. eCollection 2024.
3
Pancreatic Cancer Health Disparity: Pharmacologic Anthropology.胰腺癌的健康差异:药物人类学
Cancers (Basel). 2023 Oct 20;15(20):5070. doi: 10.3390/cancers15205070.
4
To use or not to use? an ethical analysis of access to data and samples of a deceased patient for genetic diagnostic and research purposes.使用还是不使用?对已故患者的数据和样本用于基因诊断及研究目的的伦理分析。
J Med Ethics Hist Med. 2022 Dec 28;15:13. doi: 10.18502/jmehm.v15i13.11569. eCollection 2022.
5
Immortal data: a qualitative exploration of patients' understandings of genomic data.不朽的数据:对患者对基因组数据理解的定性探索。
Eur J Hum Genet. 2023 Jun;31(6):681-686. doi: 10.1038/s41431-023-01325-9. Epub 2023 Mar 31.
6
Return of Results in Genomic Research Using Large-Scale or Whole Genome Sequencing: Toward a New Normal.使用大规模或全基因组测序进行基因组研究的结果回报:迈向新常态。
Annu Rev Genomics Hum Genet. 2023 Aug 25;24:393-414. doi: 10.1146/annurev-genom-101122-103209. Epub 2023 Mar 13.
7
"If relatives inherited the gene, they should inherit the data." Bringing the family into the room where bioethics happens.“如果亲属继承了基因,他们就应该继承相关数据。” 将家庭纳入生物伦理学讨论的范畴。
New Genet Soc. 2022;41(1):23-46. doi: 10.1080/14636778.2021.2007065. Epub 2021 Dec 13.
8
Comparison of factors influencing the willingness to donate biospecimens among guardians of children with cancer and adult cancer patients.比较影响癌症患儿监护人和成年癌症患者捐赠生物样本意愿的因素。
Cancer Med. 2022 Mar;11(6):1524-1534. doi: 10.1002/cam4.4544. Epub 2022 Feb 3.
9
Return of individual research results from genomic research: A systematic review of stakeholder perspectives.基因组研究中个体研究结果的返还:利益相关者观点的系统评价。
PLoS One. 2021 Nov 8;16(11):e0258646. doi: 10.1371/journal.pone.0258646. eCollection 2021.
10
Views on genomic research result delivery methods and informed consent: a review.关于基因组研究结果传递方法和知情同意的观点:综述。
Per Med. 2021 May;18(3):295-310. doi: 10.2217/pme-2020-0139. Epub 2021 Apr 6.

本文引用的文献

1
Attitudes Toward Return of Genetic Research Results to Relatives, Including After Death: Comparison of Cancer Probands, Blood Relatives, and Spouse/Partners.对将基因研究结果返还给亲属(包括在亲属去世后)的态度:癌症先证者、血亲及配偶/伴侣的比较
J Empir Res Hum Res Ethics. 2018 Jul;13(3):295-304. doi: 10.1177/1556264618769165. Epub 2018 Apr 27.
2
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.明显散发型胰腺腺癌患者中的有害生殖系突变
J Clin Oncol. 2017 Oct 20;35(30):3382-3390. doi: 10.1200/JCO.2017.72.3502. Epub 2017 Aug 2.
3
Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.有阳性家族史的胰腺癌患者中癌症基因种系突变的流行率。
Genet Med. 2018 Jan;20(1):119-127. doi: 10.1038/gim.2017.85. Epub 2017 Jul 20.
4
Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs).临床基因组测序与人群对“偶然”发现信息的偏好——从医学可操作基因(MAGs)到患者可操作基因(PAGs)。
PLoS One. 2017 Jul 3;12(7):e0179935. doi: 10.1371/journal.pone.0179935. eCollection 2017.
5
Lost in translation: returning germline genetic results in genome-scale cancer research.翻译中的迷失:在基因组规模癌症研究中返回种系基因结果
Genome Med. 2017 Apr 28;9(1):41. doi: 10.1186/s13073-017-0430-4.
6
Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.利益相关者对全基因组和全外显子组测序中次要发现的看法:对定量和定性研究的系统评价
Genet Med. 2017 Mar;19(3):283-293. doi: 10.1038/gim.2016.109. Epub 2016 Sep 1.
7
'Is this knowledge mine and nobody else's? I don't feel that.' Patient views about consent, confidentiality and information-sharing in genetic medicine.“这些知识是我的,别人都没有吗?我不这么觉得。”患者对基因医学中知情同意、保密和信息共享的看法。
J Med Ethics. 2016 Mar;42(3):174-9. doi: 10.1136/medethics-2015-102781. Epub 2016 Jan 7.
8
Patients' Choices for Return of Exome Sequencing Results to Relatives in the Event of Their Death.患者去世后将外显子组测序结果返还给亲属的患者选择。
J Law Med Ethics. 2015 Fall;43(3):476-85. doi: 10.1111/jlme.12290.
9
Preferences Regarding Return of Genomic Results to Relatives of Research Participants, Including after Participant Death: Empirical Results from a Cancer Biobank.关于向研究参与者亲属反馈基因组结果的偏好,包括参与者死亡后:癌症生物样本库的实证结果
J Law Med Ethics. 2015 Fall;43(3):464-75. doi: 10.1111/jlme.12289.
10
Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations.向研究参与者的亲属反馈基因组结果:分析与建议。
J Law Med Ethics. 2015 Fall;43(3):440-63. doi: 10.1111/jlme.12288.